We are live on ! Find out more
OPHC icon

OptimumBank Holdings

3 hedge funds and large institutions have $19K invested in OptimumBank Holdings in 2016 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.32% less ownership

Funds ownership: 0.76% → 0.44% (-0.32%)

25% less funds holding

Funds holding: 4 → 3 (-1)

44% less capital invested

Capital invested by funds: $34K → $19K (-$15K)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 1

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
3
Holders Change
-1
Holders Change %
-25%
% of All Funds
0.08%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
1
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
TRCT
Tower Research Capital (TRC)
New York
-$6K
2
UBS Group
UBS Group
Switzerland
-$4.39K

OPHC Hedge Fund Activity: Q2 2016 in Review

3 of the 3,756 institutional investors tracked by Wall St. Rank reported a position in OptimumBank Holdings (OPHC) for Q2 2016, worth a combined $19K — down 44% from $34K a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of OPHC and 0 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 0 added.

The largest seller was Tower Research Capital (TRC), exiting entirely with an estimated $6K sold.

  • 3 institutional investors held OptimumBank Holdings (OPHC) as of Q2 2016, down from 4 in Q1 2016.
  • Funds reported $19K of OptimumBank Holdings stock for Q2 2016, down 44% quarter-over-quarter.
  • 0 funds opened new OptimumBank Holdings positions in Q2 2016 and 1 closed out, a net change of -1 holder.
  • The largest OptimumBank Holdings seller in Q2 2016 was Tower Research Capital (TRC), an estimated $6K sold.

Based on aggregated 13F filings for Q2 2016.